Search results
Is Viking Therapeutics Stock a Buy?
The Motley Fool via AOL· 5 days agoAnd the majority of the adverse side... is going to meet with the Food and Drug Administration ...
Survey Suggests 1 in 8 US Adults May Have Used a GLP-1 Drug
Medscape· 6 days agoA KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took...
Health or hype? ABC7 investigates the supplement craze
ABC 7 Gulfshore News· 5 days agoExperts say some of the benefits may be exaggerated, and you may be able to get your nutrients...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
Tri-County Times· 5 days ago- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)